SCHEMBL20041792

SCHEMBL20041792

COc1cc(F)c(C2CC(=O)N(CC(N)=O)C2)c(F)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
FPR1 P21462 5/20 0.41
ALDH1A1 P00352 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
DPP4 P27487 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
FPR2 P25090 2/20 0.36
LMNA P02545 1/20 0.36
CPS1 P31327 1/20 0.36
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18117735 0.89 SMN1; SMN2 (0.51) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL19559464 0.89 SMN1; SMN2 (0.51) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL18117762 0.86 SMN1; SMN2 (0.53) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL18117776 0.85 ALDH1A1 (0.47) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL19559456 0.85 ALDH1A1 (0.47) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL20041907 0.84 SMN1; SMN2 (0.41) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL19559544 0.83 SMN1; SMN2 (0.51) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL18117771 0.82 FPR1 (0.54) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL19559542 0.82 SMN1; SMN2 (0.42) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2
SCHEMBL19559458 0.82 FPR1 (0.54) SMN1; SMN2FPR1ALDH1A1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305763-A1 DEUTERATED OR ISOTOPICALLY LABELED UREA DERIVATIVES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF USEFUL AS FPRL-1 AGONISTS Kyorin Pharmaceutical Co., Ltd. (JP) 2018-04-11 EP disclosed